Streptococcus pneumoniae induces secretion of vascular endothelial growth factor by human neutrophils

Infection and Immunity

Volumn 68, Issue 8, 2000, Pages 4792-4794

  Van Der Flier, Michiel Der ^a,b   Coenjaerts, Frank ^b,c   Kimpen, Jan L L ^a   Hoepelman, Andy M ^b,c   Geelen, Sibyl P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOCHALASIN B; PNEUMOLYSIN; VASCULOTROPIN;

ARTICLE; BACTERIAL CELL WALL; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; EDEMA; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN SECRETION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL CAPSULES; CAPILLARY PERMEABILITY; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; LYMPHOKINES; NEUTROPHILS; STREPTOCOCCUS PNEUMONIAE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033914377     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.8.4792-4794.2000     Document Type: Article

References (19)

1. Boesiger, J., M. Tsai, M. Yamaguchi, L. F. Brown, K. P. Claffey, H. F. Dvorak, and S. J. Galli. 1998. Mast cells can secrete vascular permeability factor/vascular endothelial growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J. Exp. Med. 188:1135-1145.
2. Fava, R. A., N. J. Olsen, G. Spencer-Green, K. Yeo, B. Berse, R. W. Jackman, D. R. Senger, H. F. Dvorak, and L. F. Brown. 1994. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180: 341-346.
3. Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxton, K. J. Hillan, and M. W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
4. Gaudry, M., O. Bregerie, V. Andrieu, J. El Benna, M. A. Pocidalo, and Hakim, J. 1997. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90:4153-4161.
5. Heiss, J. D., E. Papavassiliou, M. J. Merrill, L. Nieman, J. J. Knightly, S. Walbridge, and N. A. Edwards. 1996. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats: involvement of the glucocorticoid receptor and vascular permeability factor. J. Clin. Investig. 98:1400-1408.
6. Kolch, W., G. Martiny-Baron, A. Kieser, and D. Marme. 1995. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res. Treat. 36:139-155.
7. Mariani-Kurkdjian, P., C. Doit, I. Le Thomas, V. Aujard, A. Bourrillon, and E. Bingen. 1999. Bacterial concentration in the cerebrospinal fluid in childhood meningitis. Presse Med. 28:1227-1230.
8. Mattson, E., J. Rollof, J. Verhoef, H. van Dijk, and A. Fleer. 1994. Serum-induced potentiation of tumor necrosis factor alpha production by human leukocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect. Immun. 62:3837-3843.
9. Nag, S., J. L. Takahashi, and D. W. Kilty. 1997. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J. Neuropathol. Exp. Neur. 56:912-921.
10. Nolan, C. M., and W. C. Ulmer. 1980. Enzyme immunoassay of the capsular polysaccharide of Streptococcus pneumoniae type III in cerebrospinal fluid in experimental meningitis. J. Med. Microb. 13:551-560.
11. Perez-Ruiz, M., J. Ros, M. Morales-Ruiz, M. Navasa, J. Colmenero, L. Ruiz-Del-Arbol, P. Cejudo, J. Claria, F. Rivera, V. Arrovo, J. Rodes, and W. Jimenez. 1999. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide. Hepatology 29:1057-1063.
12. Roberts, W. G. and G. E. Palade. 1995. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sxi. 108:2369-2379.
13. Thickett, D. R., L. Armstrong, and A. B. Millar. 1999. Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions. Thorax 54:707-710.
14. Troelstra, A., L. A. de Graaf-Miltenburg, T. van Bommel, J. Verhoef, K. P. van Kessel, and J. A. van Strijp. 1999. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18. J. Immunol. 162:4220-4225.
15. Tuomanen, E., H. Liu, B. Hengstler, O. Zak, and A. Tomasz. 1985. The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151:859-868.
16. Tuomanen, E., R. Rich, and O. Zak. 1987. Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am. Rev. Respir. Dis. 135:869-874.
17. Tuomanen, E., A. Tomasz, B. Hengstler, and O. Zak. 1985. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J. Infect. Dis. 151:535-540.
18. Xiong, M., G. Elson, D. Legarda, and S. J. Leibovich. 1998. Production of vascular endothelial growth factor by murine macrophages. Am. J. Pathol. 153:587-598.
19. Yeo, K., H. H. Wang, J. A. Nagy, T. M. Sioussat, S. R. Ledbetter, A. J. Hoogewerf, Y. Zhou, E. M. Masse, D. R. Senger, H. F. Dvorak, and T. Yeo. 1993. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor effusions. Cancer Res. 53:2912-2918.